1. How many patients are currently (past 3 months) undergoing treatment for melanoma, and how many of these are BRAF+ ?
2. For patients currently (past 3 months) under treatment for melanoma
a. How many patients are Stage IIIa?
b. How many patients are Stage III resectable?
c. How many Stage III patients received a complete resection in the past 3 months?
3. In the past 3 months, how many melanoma patients were treated with the following:
d. Dabrafenib AND Trametinib
f. Encorafenib AND Binimetinib
h. Ipilimumab AND Nivolumab
m. Vemurafenib AND Cobimetinib
n. Other active systemic anti-cancer therapy
o. Palliative care only
4. In the past 3 months how many patients were treated with the following for breast cancer?
a. Abemaciclib + Anastrozole/Exemestane/Letrozole
b. Abemaciclib + Fulvestrant
c. Alpelisib + Fulvestrant
g. Everolimus + Exemestane
h. Fulvestrant as a single agent
i. Gemcitabine + Paclitaxel
m. Palbociclib + Anastrozole/Exemestane/Letrozole
n. Palbociclib + Fulvestrant
o. Pertuzumab + Trastuzumab + Docetaxel
p. Ribociclib + Anastrozole/Exemestane/Letrozole
q. Ribociclib + Fulvestrant
s. Transtuzumab + Paclitaxel
t. Transtuzumab as a single agent
u. Trastuzumab emtansine
v. Any other active systemic anti-cancer therapy